Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL) (LenD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01459211
Recruitment Status : Completed
First Posted : October 25, 2011
Last Update Posted : November 8, 2016
Information provided by (Responsible Party):
University College, London

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2016
  Study Completion Date : February 2016